Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Breast Neoplasms × elacestrant × Clear all

Phase

Status

Sponsor Class

OTHER 8 INDUSTRY 7 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Cyclophosphamide 35 Docetaxel 27 Tamoxifen 26 Paclitaxel 24 Doxorubicin 22 Trastuzumab 20 Radiotherapy 17 Epirubicin 14 Letrozole 13 Fluorouracil 10 Immunohistochemistry 9 Capecitabine 9 exemestane 8 Bevacizumab 8 Anastrozole 8 Methotrexate 7 Gene Expression Profiling 7 Filgrastim 7 Microarray Analysis 6 Lapatinib 6 Goserelin 6 Chemotherapy, Adjuvant 6 Amplified Fragment Length Polymorphism Analysis 6 palbociclib 5 Zoledronic Acid 5 Fulvestrant 5 Carboplatin 5 Absorptiometry, Photon 5 Vinorelbine 4 Surgical Procedures, Operative 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05512364 2025-08-19

TREAT ctDNA

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡